This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
HEAT SHOCK PROTEIN 90 BETA antibody
catalog :
VMA00082KT
quantity :
2 Westerns
price :
108 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
product information
EntityType :
PrecisionAbâ„¢ Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00082KT
Description :
HEAT SHOCK PROTEIN 90 BETA ANTIBODY WITH CONTROL LYSATE
Specificity :
HEAT SHOCK PROTEIN 90 BETA
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
WB
ApplicationTypes :
Western Blotting
CrossReactivities :
Mouse, Rat
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0051082, GO:0006457, GO:0006986, GO:0005829, GO:0005524, GO:0007411, GO:0030235, GO:0030911, GO:0032435, GO:0042470, GO:0045429, GO:0060334, GO:0060338
GOTerms :
activation of nitric oxide biosynthetic process, alpha-tubulin folding, axon chemotaxis, axon growth cone guidance, axon pathfinding, beta-tubulin folding, binding unfolded ER proteins, chaperone activity, chaperonin ATPase activity, chaperonin-mediated tubulin folding, co-chaperone activity, co-chaperonin activity, down regulation of proteasomal ubiquitin-dependent protein catabolic process, down-regulation of proteasomal ubiquitin-dependent protein catabolic process, downregulation of proteasomal ubiquitin-dependent protein catabolic process, fimbrium-specific chaperone activity, glycoprotein-specific chaperone activity, GO:0007022, GO:0007024, GO:0007025, GO:0008040, heat shock protein activity, histone-specific chaperone activity, inhibition of proteasomal ubiquitin-dependent protein catabolic process, nitric oxide synthase regulator activity, non-chaperonin molecular chaperone ATPase activity, positive regulation of nitric oxide anabolism, positive regulation of nitric oxide biosynthesis, positive regulation of nitric oxide formation, positive regulation of nitric oxide synthesis, protein complex assembly, multichaperone pathway, regulation of gamma-interferon-mediated signaling pathway, regulation of immune interferon signaling pathway, regulation of interferon-gamma-mediated signalling pathway, regulation of type I interferon-mediated signalling pathway, regulation of type II IFN-mediated signaling pathway, regulation of type II interferon-mediated signaling pathway, ribosomal chaperone activity, stimulation of nitric oxide biosynthetic process, tubulin-specific chaperone activity, up regulation of nitric oxide biosynthetic process, upregulation of nitric oxide biosynthetic process, up-regulation of nitric oxide biosynthetic process
UniprotAccessions :
P08238
Gene :
HSP90AB1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3326
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.